How Will Patent Expiry and Generic Competition Impact the Promacta Market?
Promacta Market is entering a transitional phase as pharmaceutical companies prepare for patent expiry and the potential entry of generic competitors. The market was valued at USD 2,216 Million in 2024 and is forecast to reach USD 2,802 Million by 2030, growing at a CAGR of 4.9% during the forecast period. According to the Eltrombopag Market competitive landscape report, increasing interest...
0 Comments 0 Shares 141 Views 0 Reviews
Sponsored